C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today highlighted its novel DNA-encoded ...
The posters and presentation slides will be made available on the Investors section of the Pharvaris website at the beginning of the respective presentations at: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results